PET/CT is primarily used in oncology for the detection of cancer. It is used to determine whether a lesion is benign or malignant. It is indicated for the assessment of tumor response to therapy. PET/CT is also indicated for the early detection of suspected recurrent tumors and for the diagnosis of metastatic disease.
PET/CT is indicated in a wide variety of cancer including:
·Head and Neck Cancers
There are neurological applications of PET/CT including the evaluation of patients with memory impairment, Alzheimer’s disease, Parkinson’s disease, seizure disorders and brain tumors.
There are cardiac applications of PET/CT, such as the assessment of blood flow to the heart muscle and tissue viability from prior heart attacks.